Jhunjhunwala continues to bet on the pharma sector and Aurobindo Pharma is his preferred pick, which has rallied a little over 6 per cent i...

Last week, Lupin, Cadila Healthcare and Alembic Pharma received clearances from the US regulator for their key facilities.

Nifty Pharma index is down over 20% from its 52-week high of 13,753.50, which indicates a bearish phase for the index. Glenmark, Cipla are ...

In this space, ETMarkets tracks the elite 30 from the Sensex pack and 50 from the nimble Nifty LIVE to help you understand why the market m...

M-cap of Sun Pharma exceeded Rs 1 lakh cr and exceeds total value of DRL, Lupin & Cipla. Sun Pharma is now the 14th most valuable co.